BriaCell Therapeutics Corp.
BCTX · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,375 | -$11,057 | -$8,717 | -$9,063 |
| Dep. & Amort. | $37 | $36 | $38 | $38 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $316 | $573 | -$1,514 | $1,171 |
| Other Non-Cash | $331 | -$756 | $88 | -$698 |
| Operating Cash Flow | -$10,691 | -$11,204 | -$10,105 | -$8,551 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$104 | -$10,251 | -$148 | -$108 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$104 | -$10,251 | -$148 | -$108 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $18,683 | $20,704 | $7,695 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $18,683 | $20,704 | $7,695 |
| Forex Effect | -$79 | $15 | -$122 | -$210 |
| Net Chg. in Cash | -$10,874 | -$2,756 | $10,329 | -$1,174 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,676 | $17,184 | $6,902 | $8,537 |
| End Cash | $3,802 | $14,428 | $17,231 | $7,363 |
| Free Cash Flow | -$10,691 | -$11,204 | -$10,105 | -$8,551 |